![Andrew Guggenhime](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Guggenhime
Directeur Financier/CFO chez
VAXCYTE, INC.
Fortune : 5 M $ au 31/05/2026
Profil
Andrew L.
Guggenhime is Chairman at Caribou Biosciences, Inc. since 2021.
Mr. Guggenhime is President & Chief Financial Officer at Vaxcyte, Inc. since 2023.
Former roles include Director at CardioDx, Inc. from 2014 to 2016, Independent Director at Metacrine, Inc. from 2018 to 2023, Assistant VP-Real Estate Capital Markets Group at Wells Fargo & Co., Chief Financial Officer & Senior Vice President at Neoforma, Inc. from 2000 to 2006, Chief Financial Officer at Calistoga Pharmaceuticals, Inc. from 2010 to 2011, Chief Financial Officer & Senior Vice President at Abbott Biotherapeutics Corp.
from 2008 to 2010, Chief Financial Officer & Senior Vice President at PDL BioPharma, Inc. from 2006 to 2008, Chief Financial Officer at Dermira, Inc. from 2018 to 2020, and Vice President at Merrill Lynch & Co., Inc. from 1996 to 2000.
Education includes undergraduate studies at Middlebury College and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VAXCYTE, INC. 0,07 % | 31/03/2026 | 96 843 ( 0,07 % ) | 5 M $ | 31/05/2026 |
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Andrew Guggenhime
| Sociétés | Poste | Début |
|---|---|---|
| VAXCYTE, INC. | Directeur Financier/CFO | 01/05/2020 |
| CARIBOU BIOSCIENCES, INC. | Président | 01/07/2021 |
Anciens postes connus de Andrew Guggenhime
| Sociétés | Poste | Fin |
|---|---|---|
| METACRINE, INC. | Directeur/Membre du Conseil | 23/03/2023 |
| DERMIRA, INC. | Directeur Financier/CFO | 01/05/2020 |
| CARDIODX INC | Directeur Financier/CFO | 28/04/2014 |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur Financier/CFO | 01/04/2011 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Directeur Financier/CFO | 01/06/2010 |
Formation de Andrew Guggenhime
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
65
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Wells Fargo & Co.
 Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services | Finance |
Neoforma, Inc.
 Neoforma, Inc. Medical DistributorsDistribution Services Provides e-commerce services to healthcare industry | Distribution Services |
CardioDx, Inc.
 CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metacrine, Inc.
 Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
